LGND - LIGAND PHARMACEUTICALS INC

QQQ $ 612.14 $ 1.56 (0.26 %)

DIA $ 470.45 $ 1.64 (0.35 %)

SPY $ 672.31 $ 2.95 (0.44 %)

TLT $ 89.45 $ -0.19 (-0.21 %)

GLD $ 367.77 $ 0.35 (0.1 %)

Previous Close

$ 202.48

Open

$ 205.45

Bid

$ 200.39 x 1

Ask

$ 219.58 x 15

Day's Range

$ 201.87 - $ 207.25

52 Week Range

$ 93.58 - $ 211.92

Volume

209,219

Average Volume

Market Cap

3.99B

Beta (5Y Monthly)

$ 1.24

PE Ratio (TTM)

$ 82.03

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-07-2025	09-30-2025	10-Q
2	08-08-2025	06-30-2025	10-Q
3	05-09-2025	03-31-2025	10-Q
4	02-28-2025	01-01-1970	10-K
5	11-08-2024	09-30-2024	10-Q
6	08-07-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	02-29-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-09-2023	06-30-2023	10-Q
11	05-08-2023	03-31-2023	10-Q
12	02-28-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-09-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-09-2021	09-30-2021	10-Q
18	08-03-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	11-06-2020	09-30-2020	10-Q
22	08-07-2020	06-30-2020	10-Q
23	05-08-2020	03-31-2020	10-Q
24	02-27-2020	12-31-2019	10-K
25	11-08-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-09-2019	03-31-2019	10-Q
28	02-28-2019	12-31-2018	10-K
29	11-08-2018	09-30-2018	10-Q
30	08-08-2018	06-30-2018	10-Q
31	05-09-2018	03-31-2018	10-Q
32	03-01-2018	12-31-2017	10-K
33	11-09-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-09-2017	03-31-2017	10-Q
36	02-28-2017	12-31-2016	10-K
37	11-15-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	05-09-2016	03-31-2016	10-Q
40	02-26-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Benchmark Maintains Buy on Ligand Pharmace...
11/07/2025 15:44:17

Benchmark analyst Robert Wasserman maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raises the price target fro...

HC Wainwright & Co. Maintains Buy on Ligan...
11/06/2025 18:30:31

HC Wainwright & Co. analyst Joseph Pantginis maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raises the pr...

Ligand Pharmaceuticals Raises FY2025 Adj E...
11/06/2025 12:10:39

2025 Financial GuidanceLigand is increasing its 2025 full year financial guidance. The Company now expects total core revenue o...

Ligand Pharmaceuticals Q3 Adj. EPS $3.09 B...
11/06/2025 12:07:54

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

What's Next: Ligand Pharmaceuticals's Earn...
11/05/2025 17:02:48

Oppenheimer Maintains Outperform on Ligand...
11/03/2025 15:47:16

Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price targ...

Ligand's Captisol Technology Powers New FD...
10/09/2025 11:16:10

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its partner SQ Innovation Inc. has received approval fro...

Arecor And Ligand Pharmaceuticals Sign Roy...
09/25/2025 06:54:40

Co-development Agreement with US Insulin Pump Device Company for AT278 and Sale of Royalty and Technology Access Fees for up to...

Oppenheimer Maintains Outperform on Ligand...
09/03/2025 14:43:19

Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price targ...

What Analysts Are Saying About Ligand Phar...
09/02/2025 22:01:24

Benchmark Maintains Buy on Ligand Pharmace...
09/02/2025 13:44:50

Benchmark analyst Robert Wasserman maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raises the price target fro...

HC Wainwright & Co. Maintains Buy on Ligan...
08/28/2025 16:34:15

HC Wainwright & Co. analyst Joseph Pantginis maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raises the pr...

Reported Earlier, Ligand Pharmaceuticals P...
08/12/2025 07:28:57

Ligand Pharmaceuticals To Offer $400M Conv...
08/11/2025 11:15:47

RBC Capital Maintains Outperform on Ligand...
08/08/2025 18:17:44

RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price targ...

Ligand Pharmaceuticals Raises FY2025 Adj E...
08/07/2025 11:03:18

25 Financial GuidanceLigand is increasing its 2025 full year financial guidance. The Company now expects total revenue of $200 ...

Ligand Pharmaceuticals Q2 Adj. EPS $1.60 B...
08/07/2025 11:02:32

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate o...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Orchestra BioMed Secures $111M From Medtro...
08/05/2025 11:14:13

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company"))), a biomedical company acce...